Fbd Biologics Limited
Clinical trials sponsored by Fbd Biologics Limited, explained in plain language.
Upcoming readouts
Trials from this sponsor expected to report results within the next 12 months.
- New drug HCB301 enters early human trials for tough cancers Results expected Dec 2026 (estimated)
- New drug HCB101 enters human trials for tough cancers Results expected May 2027 (estimated)
-
New drug HCB301 enters early human trials for tough cancers
Disease control Recruiting nowThis early-phase trial is testing a new drug called HCB301 in 50 adults with advanced solid tumors or Hodgkin lymphoma that has come back or not responded to other treatments. The main goals are to check the drug's safety, find the right dose, and see if it shows any signs of shr…
Phase 1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 12:06 UTC
-
New drug HCB101 enters human trials for tough cancers
Disease control Recruiting nowThis early-stage trial tests whether the experimental drug HCB101 is safe and can shrink tumors in people with advanced solid tumors or non-Hodgkin lymphoma that has come back or not responded to other treatments. About 80 adults aged 18 and older will receive the drug by IV. The…
Phase 1 • Sponsor: FBD Biologics Limited • Aim: Disease control
Last updated Jun 27, 2026 09:01 UTC